Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)

Artak Labadzhyan, L. B. Nachtigall, M. Fleseriu, M. B. Gordon, M. Molitch, L. Kennedy, S. L. Samson, Y. Greenman, N. Biermasz, M. Bolanowski, A. Haviv, W. Ludlam, G. Patou, C. J. Strasburger

Research output: Contribution to journalComment/debate

Abstract

The article ‘Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results’, written by Artak Labadzhyan, L B Nachtigall, M Fleseriu, M B Gordon, M Molitch, L Kennedy, S L Samson, Y Greenman, N Biermasz, M Bolanowski, A Haviv, W Ludlam, G Patou and C J Strasburger was originally published electronically on the publisher’s internet portal on 25 June 2021 without open access.

Original languageEnglish
Pages (from-to)954
Number of pages1
JournalPituitary
Volume24
Issue number6
DOIs
StatePublished - Dec 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)'. Together they form a unique fingerprint.

Cite this